Welcome to our dedicated page for GENESCO SEC filings (Ticker: GCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on GENESCO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into GENESCO's regulatory disclosures and financial reporting.
Genesco Inc. (GCO) reported fiscal 2027 second-quarter results showing a sharp profitability improvement despite modestly lower sales. Net sales were $529.9 million, down 3% from $546.0 million a year earlier, while total comparable sales declined 1% as store comps rose 1% and e-commerce fell 6%.
Gross margin expanded to 51.4% from 45.8%, boosted by $21.8 million of tariff refunds; adjusted gross margin improved to 47.2%, up 140 basis points. GAAP operating income was $3.6 million versus a $14.4 million loss, and GAAP EPS was $0.32 compared with a loss of $1.79 per share. Excluding one-time items, the company reported a second-quarter loss of $0.83 per share, better than the $1.14 loss last year, with adjusted operating margin improving to a 1.6% loss from a 2.6% loss.
Journeys and Johnston & Murphy delivered positive comparable sales of 2% and 4%, respectively, while Schuh comps declined 9%. Genesco cut total debt to $15.8 million from $71.0 million, ended the quarter with $57.1 million in cash and approximately $394 million of total liquidity, and closed its store base by 5% year over year to 1,186 locations. Management raised full-year adjusted EPS guidance to the high end of $2.00 to $2.40 and expects operating income at the high end of the prior $34 to $40 million range, while now projecting flat comparable sales and total sales down about 2%.
Fund 1 Investments, LLC reported a beneficial ownership position in Genesco Inc.609,963 shares, representing 5.49% of the outstanding common stock, calculated using 11,106,973 shares outstanding as of May 29, 2026 as disclosed by Genesco.
Fund 1 Investments has shared voting and dispositive power over all 609,963 shares and no sole voting or dispositive power. The shares are held by private investment vehicles advised by Pleasant Lake Partners LLC, for which Fund 1 Investments serves as managing member. The reporting person disclaims beneficial ownership except to the extent of its pecuniary interest. The funds have the right to receive or direct the receipt of dividends and sale proceeds for more than five percent of the class.
Genesco Inc. disclosed that Senior Vice President and Chief Strategy and Digital Officer Parag D. Desai will transition from full-time to part-time status effective August 7, 2026 and is expected to retire on October 31, 2026. During this transition period, he will retain his title for transition purposes, work a limited number of hours each month to hand off responsibilities and support onboarding of other executives, and receive $10,000 per month for up to 32 hours, with additional hours paid pro rata.
Desai will remain eligible for the Company’s Fiscal 2027 Short-Term Incentive Plan with a $338,000 target bonus, and his April 2024 and July 2025 performance share unit awards will receive retirement treatment. After retirement, he will provide consulting services from November 1, 2026 through January 31, 2027 at $2,400 per day. Genesco stated that his responsibilities will transition to other senior leaders.
Collins Jonathan M. reported acquisition or exercise transactions in this Form 4 filing.
GENESCO INC SVP Finance and CFO Jonathan M. Collins received a grant of 11,424 shares of restricted common stock at $0.00 per share under the Fourth Amended and Restated 2020 Equity Incentive Plan. The award vests in three equal tranches on August 3, 2027, April 4, 2028, and April 4, 2029, and Collins holds 11,424 shares directly after this grant.
Genesco Inc. officer Jonathan M. Collins, SVP Finance and CFO, filed an initial statement of beneficial ownership on Form 3. The filing reports direct ownership of 0 shares of Common Stock as of August 3, 2026, with no derivative securities or reportable buy/sell transactions listed.
Bradley L. Radoff and Jumana Capital Investments LLC, managed by Christopher R. Martin, ended their coordinated activities regarding Genesco Inc. common stock on August 3, 2026 under a Termination Agreement and state they no longer form a Section 13(d) group or collectively beneficially own over 5% of the shares.
Radoff directly beneficially owns 480,000 shares, and Jumana Capital directly beneficially owns 535,000 shares. Based on 11,106,973 shares outstanding as of June 11, 2026, these positions represent approximately 4.3% and 4.8%, respectively. Radoff’s shares were purchased with personal funds for about $13,776,359, and Jumana Capital’s with working capital for about $16,438,218, which may include margin loans.
Barsh Joanna reported acquisition or exercise transactions in this Form 4 filing.
Genesco Inc director Joanna Barsh reported receiving a grant of 3,905 shares of restricted common stock on 2026-07-24 under the Fourth Amended and Restated 2020 Equity Incentive Plan at $0.00 per share. After this award, she directly holds 49,802 shares of Genesco common stock.
SANDFORT GREGORY A reported acquisition or exercise transactions in this Form 4 filing.
Genesco Inc. reported a Form 4 transaction for director Gregory A. Sandfort, who received a grant of 3,905 shares of Common Stock as restricted stock on 2026-07-24 under the Fourth Amended and Restated 2020 Equity Incentive Plan. The award was priced at $0.00 per share, increasing his direct holdings to 22,535 shares.
Bilunas Matthew M reported acquisition or exercise transactions in this Form 4 filing.
Genesco Inc director Matthew M. Bilunas received a grant of 3,905 shares of common stock on 2026-07-24 as restricted stock under the company's Fourth Amended and Restated 2020 Equity Incentive Plan, increasing his directly held stake to 19,006 shares.
Bojanowski Carolyn reported acquisition or exercise transactions in this Form 4 filing.
Genesco Inc. director Carolyn Bojanowski received a grant of 3,905 shares of restricted common stock under the company’s Fourth Amended and Restated 2020 Equity Incentive Plan. The award carried a reported price of $0.00 per share, and she now directly holds 19,006 Genesco common shares.